1. Home
  2. GLBE vs DNTH Comparison

GLBE vs DNTH Comparison

Compare GLBE & DNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Global-E Online Ltd.

GLBE

Global-E Online Ltd.

N/A

Current Price

$35.29

Market Cap

7.0B

Sector

Technology

ML Signal

N/A

Logo Dianthus Therapeutics Inc.

DNTH

Dianthus Therapeutics Inc.

N/A

Current Price

$85.40

Market Cap

5.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
GLBE
DNTH
Founded
2013
2015
Country
Israel
United States
Employees
N/A
N/A
Industry
Computer Software: Prepackaged Software
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
7.0B
5.9B
IPO Year
2020
2018

Fundamental Metrics

Financial Performance
Metric
GLBE
DNTH
Price
$35.29
$85.40
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
13
18
Target Price
$50.92
★ $139.25
AVG Volume (30 Days)
★ 1.6M
723.8K
Earning Date
11-18-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $2,036,000.00
Revenue This Year
$39.66
$22.80
Revenue Next Year
$29.71
N/A
P/E Ratio
$89.26
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$26.85
$35.84
52 Week High
$45.28
$117.88

Technical Indicators

Market Signals
Indicator
GLBE
DNTH
Relative Strength Index (RSI) 32.17 49.43
Support Level $34.70 $79.54
Resistance Level $37.38 $91.36
Average True Range (ATR) 1.95 4.91
MACD -0.77 0.31
Stochastic Oscillator 4.33 40.36

Price Performance

Historical Comparison
GLBE
DNTH

About GLBE Global-E Online Ltd.

Global E Online Ltd provides e-commerce solutions. The company offers a platform to enable and accelerate direct-to-consumer cross-border e-commerce. The platform was purpose-built for international shoppers to buy seamlessly online and for merchants to sell from, and to, anywhere in the world. The company localizes the shopper experience to make international transactions as seamless as domestic ones. The platform increases the conversion of international traffic into sales by removing much of the complexity associated with international e-commerce. The company derives maximum revenue from the United States.

About DNTH Dianthus Therapeutics Inc.

Dianthus Therapeutics Inc. is a clinical-stage biotechnology company dedicated to developing potentially best-in-class therapies for patients with severe autoimmune diseases. The company operates as a single segment and has one reportable segment, focusing on creating next-generation treatments to revolutionize the management of severe autoimmune conditions. The team comprises experienced biotech and pharma executives. The pipeline includes the potential of Claseprubart, a next-generation complement therapeutic.

Share on Social Networks: